IRWD vs MS · P/E 5.7, rev $219.5M vs P/E 20, rev $41.93B
Ironwood Pharmaceuticals Inc (IRWD) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Latest reported MS revenue for 2026-06-30 was $41.93B. Net income was $11.15B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the IRWD and MS stock pages for the full models.
Not investment advice.